Ethics of Pharmacological Research Involving Adolescents
- 19 December 2014
- journal article
- review article
- Published by Springer Science and Business Media LLC in Pediatric Drugs
- Vol. 17 (1), 55-59
- https://doi.org/10.1007/s40272-014-0114-0
Abstract
Pharmacological research in the adolescent population is not meeting adolescents' needs. Medication is still frequently prescribed off label, and studies especially in sensitive areas of adolescent health care are underrepresented. Adolescents did not benefit from the new knowledge gained in cancer research, and their outcome has essentially not improved during the last two decades in comparison to younger children and adults. There are many obstacles that make it challenging to enroll adolescents in pharmacological research. Access can be difficult. Confidentiality plays an essential role for minors and may be a hindrance, notably to studying sexual and mental health matters. Pharmaceutical companies may exclude the adolescent patient because of a lack of profit and in fear of a complex study design. Research concepts should be explained to the adolescent in a comprehensive manner, and assent and consent forms should be clear and understandable. New laws and incentives have been developed to encourage pharmaceutical companies to engage adolescents in their research projects. Centralization and collaboration of all parties involved may make the whole approach to adolescent research more efficient and uniform. The mature minor doctrine has facilitated the enrollment process. Parental consent may be waived for low-risk medical trials to promote recruitment. Ethics committees therefore play a major role in protecting the adolescent from harm from participating in research. In conclusion, pharmacological research in adolescents has to be encouraged. This will increase the safety of current medical treatment regimens and will allow this population to benefit from therapeutic advancements.Keywords
This publication has 29 references indexed in Scilit:
- Fuzzy Trace Theory and Medical Decisions by Minors: Differences in Reasoning between Adolescents and AdultsJournal of Medicine and Philosophy, 2013
- Summary of the National Institute of Child Health and Human Development–Best Pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop–Pediatric Biopharmaceutics Classification System Working GroupClinical Therapeutics, 2012
- A New Justification for Pediatric Research Without the Potential for Clinical BenefitAmerican Journal of Bioethics, 2012
- Ethical issues in psychopharmacology of children and adolescentsCurrent Opinion in Psychiatry, 2008
- Comparisons of adolescent and parent willingness to participate in minimal and above-minimal risk pediatric asthma research protocolsJournal of Adolescent Health, 2005
- A literature review on off-label drug use in childrenEuropean Journal of Pediatrics, 2005
- Confidential health care for adolescents: position paper of the Society for Adolescent MedicineJournal of Adolescent Health, 2004
- Clinical Trials in ChildrenPediatric Drugs, 2000
- Drug trials in children: problems and the way forwardBritish Journal of Clinical Pharmacology, 2000
- Lack of Benefit of a Single Dose of Synthetic Human Secretin in the Treatment of Autism and Pervasive Developmental DisorderThe New England Journal of Medicine, 1999